Cargando…
EHMTI-0273. Onabotulinotoxin type A is a therapeutic option in chronic cluster headache
Autores principales: | Mas-Sala, N, Quintana, M, Alvarez-Sabin, J, Pozo-Rosich, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181471/ http://dx.doi.org/10.1186/1129-2377-15-S1-C51 |
Ejemplares similares
-
EHMTI-0283. Predictors of early response to onabotulinumtoxin type a in chronic migraine
por: Mas-Sala, N, et al.
Publicado: (2014) -
EHMTI-0270. Experience with onabotulinumtoxin type a in high-frequency episodic migraine
por: Pozo-Rosich, P, et al.
Publicado: (2014) -
EHMTI-0103. Errors in recognition and management are still frequent in cluster headache
por: del Río, M Sánchez, et al.
Publicado: (2014) -
EHMTI-0288. A clinical comparison demonstrates similarities between chronic and high frequency episodic migraine
por: Pozo-Rosich, P, et al.
Publicado: (2014) -
EHMTI-0081. Use of rotigotine in chronic cluster headache
por: Savi, L, et al.
Publicado: (2014)